A Study to Estimate the Immune Response Following a Challenge Dose in Adults (>=50 Years Old) Vaccinated With a Primary Series of an Hepatitis B Vaccine.

Trial Profile

A Study to Estimate the Immune Response Following a Challenge Dose in Adults (>=50 Years Old) Vaccinated With a Primary Series of an Hepatitis B Vaccine.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Aug 2017

At a glance

  • Drugs Hepatitis B vaccine recombinant (HBvaxPro) (Primary)
  • Indications Hepatitis B
  • Focus Pharmacodynamics
  • Sponsors sanofi pasteur MSD
  • Most Recent Events

    • 11 Oct 2011 Actual end date Jun 2011 added as reported by ClinicalTrials.gov.
    • 11 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Jul 2011 Planned end date changed from 1 Jun 2011 to 1 Jul 2011 as reported by ClinicalTrials.go.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top